Surgery Partners Lowers Full-Year Revenue Guidance, Stock Plummets 25.42%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 11 2025
0mins
Source: PRnewswire
- Revenue Guidance Cut: Surgery Partners has lowered its full-year revenue guidance to a range of $3.275 billion to $3.3 billion, primarily due to delays in capital deployment and lost earnings from divestitures, indicating significant uncertainty in the company's market position.
- EBITDA Forecast Adjustment: The adjusted EBITDA guidance has been revised down to between $535 million and $540 million, reflecting a cautious outlook on the commercial payer mix and volume in Q4, which may impact future profitability.
- Stock Price Plunge: Following the earnings report on November 10, Surgery Partners' stock price fell by $5.47, or 25.42%, closing at $16.04 per share, demonstrating strong investor concern regarding the company's outlook.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Surgery Partners and its executives engaged in securities fraud or other unlawful business practices, potentially leading to further legal risks and financial repercussions.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like SGRY with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on SGRY
Wall Street analysts forecast SGRY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SGRY is 26.30 USD with a low forecast of 18.00 USD and a high forecast of 36.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
8 Buy
3 Hold
0 Sell
Moderate Buy
Current: 14.850
Low
18.00
Averages
26.30
High
36.00
Current: 14.850
Low
18.00
Averages
26.30
High
36.00
About SGRY
Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility Services segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of 162 surgical facilities comprised of 143 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 250 locations in 30 states, including short-stay surgical hospitals.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Surgery Partners Announces $425 Million Private Debt Offering Pricing
Private Offering Announcement: Surgery Partners (SGRY) announced that its Surgery Center subsidiary has priced a private offering.
Financial Implications: The details regarding the amount raised and the intended use of proceeds from the offering were not specified in the announcement.
Continue Reading
Surgery Partners Prices $425 Million Senior Unsecured Notes Offering
- Bond Offering Size: Surgery Partners' wholly-owned subsidiary, Surgery Center Holdings, Inc., has successfully priced $425 million of 7.250% senior unsecured notes, expected to close on December 16, 2025, enhancing the company's financing flexibility.
- Clear Use of Proceeds: The net proceeds from this bond offering will be utilized for general corporate purposes, including repaying outstanding borrowings under its revolving credit facility, thereby optimizing the company's capital structure and reducing financial costs.
- Market Positioning: As a leading healthcare services company in the U.S., Surgery Partners operates over 200 locations across 30 states, continuously expanding its surgical services business to provide high-quality, cost-effective solutions for patients and physicians.
- Compliance and Risk Advisory: This bond offering complies with Rule 144A of the Securities Act, targeting only qualified institutional buyers, and the unregistered securities may face liquidity risks, necessitating attention to market changes that could impact the company's finances.
Continue Reading